๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Silver Products for Medical Indications: Risk-Benefit Assessment

โœ Scribed by Fung, Man C.; Bowen, Debra L.


Book ID
111672971
Publisher
Informa plc
Year
1996
Tongue
English
Weight
677 KB
Volume
34
Category
Article
ISSN
1097-9875

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Medical treatment for primary sclerosing
โœ Paul Angulo; Keith D. Lindor ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 74 KB

Background: No established medical therapy alters the progressive course of primary sclerosing cholangitis. Objective: To explore the potential usefulness of combined therapy with azathioprine, steroids and ursodeoxycholic acid (UDCA) in primary sclerosing cholangitis. Design: Case series. Setting: